US 10889637
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 10889637 (Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies) held by The Board of Regents of the University of Texas System expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61P, A61P19/10